Comparative effectiveness of shock wave lithotripsy and ureteroscopy for treating patients with kidney stones

JAMA Surgery

Volumn 149, Issue 7, 2014, Pages 648-653

  Scales Jr , Charles D ^a,b,c,d   Lai, Julie C ^e   Dick, Andrew W ^e   Hanley, Jan M ^e   Van Meijgaard, Jeroen ^f   Setodji, Claude M ^e   Saigal, Christopher S ^c,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e RAND CORPORATION   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LITHOTRIPSY; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SHOCK WAVE LITHOTRIPSY; URETEROSCOPY;

ADULT; COMPARATIVE EFFECTIVENESS RESEARCH; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; KIDNEY CALCULI; LITHOTRIPSY; MALE; MIDDLE AGED; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES; URETEROSCOPY;

EID: 84904394962     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2014.336     Document Type: Article

References (37)

1. Scales CD Jr, Smith AC, Hanley JM, Saigal CS; Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012; 62(1):160-165.
2. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63(5):1817-1823. (Pubitemid 36513328)
3. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: US Dept of Health and Human Services, Centers for Disease Control and Prevention; 2011.
4. Ljunghall S. Incidence of upper urinary tract stones. Miner Electrolyte Metab. 1987;13(4):220-227. (Pubitemid 17149573)
5. Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY. Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004;65(4):1422-1425. (Pubitemid 38406983)
6. Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K. Themetabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004;65(2):386-392. (Pubitemid 38130632)
7. Ekeruo WO, Tan YH, Young MD, et al. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol. 2004;172(1):159-163. (Pubitemid 41615062)
8. Khan SR. Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease,metabolic syndrome? Urol Res. 2012;40(2):95-112.
9. Litwin MS, Saigal CS. Table 14-47: economic impact of urologic disease. In: Urologic Diseases in America.Washington, DC: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Dept of Health and Human Services; 2012:486. NIH publication 12-7865.
10. Litwin MS, Saigal CS. Introduction. In: Urologic Diseases in America.Washington, DC: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Dept of Health and Human Services; 2007:3-7. NIH publication 07-5512.
11. Saigal CS, Joyce G, Timilsina AR; Urologic Diseases in America Project. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int. 2005;68(4):1808-1814. (Pubitemid 43169926)
12. Scales CD Jr, Krupski TL, Curtis LH, et al Urologic Diseases in America Project. Practice variation in the surgical management of urinary lithiasis. J Urol. 2011;186(1):146-150.
13. Preminger GM, Tiselius HG, Assimos DG, et al EAU/AUA Nephrolithiasis Guideline Panel. 2007 Guideline for the management of ureteral calculi. J Urol. 2007;178(6):2418-2434. (Pubitemid 350052250)
14. Matlaga BR, Jansen JP, Meckley LM, Byrne TW, Lingeman JE. Treatment of ureteral and renal stones: a systematic review and meta-analysis of randomized, controlled trials. J Urol. 2012;188(1):130-137.
15. Lingeman JE. Extracorporeal shock wave lithotripsy: what happened [comment]? J Urol. 2003;169(1):63. (Pubitemid 35461550)
16. Zehnder P, Roth B, Birkhäuser F, et al. A prospective randomised trial comparing the modified HM3 with the MODULITH SLX-F2 lithotripter. Eur Urol. 2011;59(4):637-644.
17. Chow GK, Patterson DE, Blute ML, Segura JW. Ureteroscopy: effect of technology and technique on clinical practice. J Urol. 2003;170(1):99-102. (Pubitemid 36734423)
18. Krambeck AE, Murat FJ, Gettman MT, Chow GK, Patterson DE, Segura JW. The evolution of ureteroscopy: a modern single-institution series. Mayo Clin Proc. 2006;81(4):468-473.
19. Canes D, Desai MM. New technology in the treatment of nephrolithiasis. Curr Opin Urol. 2008;18(2):235-240. (Pubitemid 351317398)
20. Emanuel EJ. Where are the health care cost savings? JAMA. 2012;307(1):39-40.
21. Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012;307(14):1513-1516.
22. Preminger GM, Tiselius HG, Assimos DG, et al American Urological Association Education and Research, Inc; European Association of Urology. 2007 Guideline for the management of ureteral calculi. Eur Urol. 2007;52(6):1610- 1631. (Pubitemid 350052433)
23. Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health. 1998;19:17-34. (Pubitemid 28279922)
24. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variablemethods. JAMA. 2007;297(3):278-285. (Pubitemid 46143305)
25. Tan HJ, Norton EC, Ye Z, Hafez KS, Gore JL, Miller DC. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA. 2012;307(15):1629-1635.
26. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acutemyocardial infarction in the elderly reduce mortality? analysis using instrumental variables. JAMA. 1994;272(11):859-866. (Pubitemid 24282095)
27. Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS,Wolf JS Jr; AUA Nephrolithiasis Guideline Panel. Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol. 2005;173(6):1991-2000.
28. Kijvikai K, Haleblian GE, Preminger GM, de la Rosette J. Shock wave lithotripsy or ureteroscopy for the management of proximal ureteral calculi: an old discussion revisited. J Urol. 2007;178(4, pt 1):1157-1163. (Pubitemid 47376712)
29. Pearle MS, Nadler R, Bercowsky E, et al. Prospective randomized trial comparing shockwave lithotripsy and ureteroscopy for management of distal ureteral calculi. J Urol. 2001;166(4):1255-1260. (Pubitemid 32862150)
30. Peschel R, Janetschek G, Bartsch G. Extracorporeal shock wave lithotripsy versus ureteroscopy for distal ureteral calculi: a prospective randomized study. J Urol. 1999;162(6):1909-1912.
31. Pearle MS, Lingeman JE, Leveillee R, et al. Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cmor less. J Urol. 2005;173(6):2005-2009. (Pubitemid 40675228)
32. Chaussy C, Schüller J, Schmiedt E, Brandl H, Jocham D, Liedl B. Extracorporeal shock-wave lithotripsy (ESWL) for treatment of urolithiasis. Urology. 1984;23(5 Spec No):59-66.
33. Finlayson B, Thomas WC Jr. Extracorporeal shock-wave lithotripsy. Ann Intern Med. 1984;101(3):387-389. (Pubitemid 14033792)
34. Bhojani N, Lingeman JE. Shockwave lithotripsy: new concepts and optimizing treatment parameters. Urol Clin North Am. 2013;40(1):59-66.
35. Mancini JG, Neisius A, Smith N, et al. Assessment of a modified acoustic lens for electromagnetic shock wave lithotripters in a swine model. J Urol. 2013;190(3):1096-1101.
36. Lotan Y, Cadeddu JA, Roehrborn CG, Stage KH. The value of your time: evaluation of effects of changes in Medicare reimbursement rates on the practice of urology. J Urol. 2004;172(5, pt 1):1958-1962. (Pubitemid 39363101)
37. Harris KM, Remler DK. Who is the marginal patient? understanding instrumental variables estimates of treatment effects. Health Serv Res. 1998;33(5, pt 1):1337-1360. (Pubitemid 29006391)